PURELL® Waterless Surgical Scrub Gel

2 fl oz Portable Flip Cap Bottle

PURELL® Waterless Surgical Scrub Gel
SKU: 9686-24
Size: 2 fl oz
SDS Downloads English Spanish

PURELL® Waterless Surgical Scrub Gel

2 fl oz Portable Flip Cap Bottle

Specially-formulated for the operating room and other high-risk areas.

  • Designed to meet and exceed FDA surgical scrub requirements*
  • Advanced formulation provides instant germ kill and persistent activity
  • 5 skin conditioners keep skin smooth and healthy
  • Only requires 2 applications
  • Dries quickly
  • Compatible with latex, neoprene and polyisoprene gloves
SKU: 9686-24
Size: 2 fl oz
SDS Downloads English Spanish

Refreshing gel formulation.

PURELL Advanced Instant Hand Sanitizer is the most trusted & used brand by hospitals.

Proven to outperform other hand sanitizers ounce for ounce.

2 fl oz
Case Pack
Case Weight
4.3 lbs
Overall Case Dimensions
4.58 h x 6.01 w x 9.32 d
Overall Unit Dimensions
3.88 h x 1.81 w x 1.06 l
Case Cu. Ft.
0.15 ft³
Cases Per Layer
Cases Per Pallet
Layers Per Pallet
Product Type Packaging
Country of Manufacture
United States
UPC (Each)

1. Apply to clean, dry hands.

2. Clean under your nails with a nail pick.

3. Dispense 2 mL of product (dispenser will automatically actuate twice) into the palm of your right hand.

4. Dip fingertips of left hand into the product and work under nails.

5. Spread remaining product evenly over your left hand and forearm. Pay attention to all skin surfaces including the nails, cuticles and web area in between fingers.

Repeat steps 2, 3 and 4 for the opposite hand and arm. Allow hands and arms to completely air dry before applying gloves (approximately one minute). IF DESIRED OR REQUIRED BY YOUR OPERATING ROOM PROTOCOL, A THIRD APPLICATION CAN BE USED FOR YOUR HANDS.

Comparative Efficacy of Alcohol-Based Surgical Scrubs: The Importance of Formulation

Read the article

Abstract: Alcohol-based surgical scrubs (ABSSs) are used to prevent surgical site infections. Chlorhexidine gluconate (CHG) often is added to enhance persistent germicidal activity. The aim of this study was to determine the influence of ABSS product formulation on efficacy. We evaluated three commercially available ABSS formulations and one control alcohol formulation according to the surgical scrub methodology specified by the US Food and Drug Administration (FDA). Only one ABSS formulation met FDA efficacy requirements when tested at the manufacturer’s recommended dosage. In contrast, two ABSS formulations, one of which contained CHG, failed to meet the FDA acceptance criteria for a 3-log10 reduction on day 5, meaning the formulations did not sufficiently reduce bacteria levels on hands on the fifth day of product application. The data suggest that recommendations to include CHG in ABSS formulations should be reconsidered, and product efficacy, skin tolerability, and user acceptability should be evaluated on a case-by-case basis.
Reference: AORN Journal, December 2014, Volume 100, Issue 6, Pages 641-650 David R Macinga, PhD; Sarah L. Edmonds, MS, CCRP; Esther Campbell, BS; Robert R. McCormick, BS

Reducing Infection Rates in Healthcare

Bacterial shedding and desquamation from the hands of healthcare workers correlates with skin condition.

Read the article

Results: Bacterial dispersal and quantitative skin measurements were obtained from 86 healthcare workers over a 3 day period. The levels of bacteria shed from the hands of the healthcare workers was found to be negatively correlated to corneometer measurements (p < 0.01); and positively correlated to desquamation index (p < 0.02). No correlation was found between levels of shed bacteria and transepidermal water loss. As expected, corneometer measurements were found to be negatively correlated to desquamation index (p < 0.0001).
Conclusion: The results of this hospital study demonstrate that the levels of bacteria shed from the hands of healthcare workers are influenced by the health of the individual's skin; i.e. dry skin sheds more bacteria. This increased bacterial dispersal from dry skin may increase the infection transfer risk for healthcare workers with poor skin condition in the acute care setting.
Reference: American Journal of Infection Control, Volume 34, Issue 5, June 2006, Pages E85-E86. C.A. Kolly, J.W. Arbogast, D.R. Macinga

*FDA Tentative Final Monograph June 2004